top of page

William (Bill) McVicar, PhD

Chief Executive Officer



  • LinkedIn


Dr. McVicar’s career in the pharmaceutical industry spans more than 30 years.  He has held numerous high ranking positions, leading teams at Novartis, RPR Gencell, and Sepracor.  He was most recently the Chief Scientific Officer of Inotek Pharmaceuticals, and the Chief Executive Officer and Director at Flex Pharmaceuticals. 


During his career, Dr. McVicar has personally overseen the development of multiple drug candidates from early testing all the way through to approval, including BROVANA®, XOPENEX MDI®, and XOPENEX’s pediatric approval.  As a C-suite executive, Dr. McVicar has raised well over $100MM in venture and public financings, lead numerous development collaborations and licensing transactions, and negotiated the merger of Flex and Salarius Pharmaceuticals.  He serves on the board of Satellos Biosciences (MSCL.V) and Salarius (SLRX) where he is the Chair.


Dr. McVicar earned his B.S. in Chemistry from SUNY College at Oneonta and his Ph.D. in Chemistry from the University of Vermont.  He is an author on numerous peer-reviewed scientific publications and an inventor on 15 issued US patents.

bottom of page